Development of a Broadly Applicable Cas12a-Linked Beam Unlocking Reaction for Sensitive and Specific Detection of Respiratory Pathogens Including SARS-CoV-2
Authors:
- 15 February 2021
- journal article
- research article
- Published by American Chemical Society (ACS) in ACS Chemical Biology
- Vol. 16 (3) , 491-500
Abstract
The outbreak of novel coronavirus SARS-CoV-2 has caused a worldwide threat to public health. COVID-19 patients with SARS-CoV-2 infection can develop clinical symptoms that are often confused with the infections of other respiratory pathogens. Sensitive and specific detection of SARS-CoV-2 with the ability to discriminate from other viruses is urgently needed for COVID-19 diagnosis. Herein, we streamlined a highly efficient CRISPR-Cas12a-based nucleic acid detection platform, termed Cas12a-linked beam unlocking reaction (CALIBURN). We show that CALIBURN could detect SARS-CoV-2 and other coronaviruses and influenza viruses with little cross-reactivity. Importantly, CALIBURN allowed accurate diagnosis of clinical samples with extremely low viral loads, which is a major obstacle for the clinical applications of existing CRISPR diagnostic platforms. When tested on the specimens from SARS-CoV-2-positive and negative donors, CALIBURN exhibited 73.0% positive and 19.0% presumptive positive rates and 100% specificity. Moreover, unlike existing CRISPR detection methods that were mainly restricted to respiratory specimens, CALIBURN displayed consistent performance across both respiratory and nonrespiratory specimens, suggesting its broad specimen compatibility. Finally, using a mouse model of SARS-CoV-2 infection, we demonstrated that CALIBURN allowed detection of coexisting pathogens without cross-reactivity from a single tissue specimen. Our results suggest that CALIBURN can serve as a versatile platform for the diagnosis of COVID-19 and other respiratory infectious diseases.Keywords
Funding Information
- Guangdong Provincial Introduction of Innovative Research and Development Team (2016ZT06Y337)
- Zhejiang University (2020XGZX011)
- Ministry of Education of the People's Republic of China (19ykzd25)
- Ministry of Science and Technology of the People's Republic of China (2018YFC1200100, 2018ZX10301403, 2020YFC0841400)
- ShanghaiTech University (2019F0301-000-01)
- National Natural Science Foundation of China (91853106)
- Shanghai Shen Kang Hospital Development Center (SHDC12018102)
- National Innovative Research Team of High-level Local Universities in Shanghai
- Zhangjiang National Innovation Demonstration Zone (ZJ2020-ZD-004)
- Cultivation Project of Shanghai Major Infectious Disease Research Base (20dz2210500)
- Key Laboratory of Emergency Prevention, Diagnosis and Treatment of Respiratory Infectious Diseases (20dz2261100)
- Shanghai Municipal Key Clinical Specialty (shslczdzk02202)
- Shanghai Top-Priority Clinical Key Disciplines Construction Project (2017ZZ02014)
This publication has 48 references indexed in Scilit:
- Two distinct RNase activities of CRISPR-C2c2 enable guide-RNA processing and RNA detectionNature, 2016
- Rapid generation of a mouse model for Middle East respiratory syndromeProceedings of the National Academy of Sciences, 2014
- RNA-Guided Human Genome Engineering via Cas9Science, 2013
- Multiplex Genome Engineering Using CRISPR/Cas SystemsScience, 2013
- Targeted genome engineering in human cells with the Cas9 RNA-guided endonucleaseNature Biotechnology, 2013
- RNA-programmed genome editing in human cellseLife, 2013
- CRISPR Interference Limits Horizontal Gene Transfer in Staphylococci by Targeting DNAScience, 2008
- Small CRISPR RNAs Guide Antiviral Defense in ProkaryotesScience, 2008
- A protocol for rapid generation of recombinant adenoviruses using the AdEasy systemNature Protocols, 2007
- CRISPR Provides Acquired Resistance Against Viruses in ProkaryotesScience, 2007